KC Coffey

KC Coffey, MD, MPH is an Assistant Professor in the Department of Epidemiology and Public Health at the University of Maryland School of Medicine and serves as Associate Hospital Epidemiologist at the Veterans Affairs Maryland Healthcare System, with board certification in Infectious Diseases, Medical Microbiology, and Internal Medicine.

Her educational background includes:

• Boston University, BA in English, 2003
• Tulane University School of Public Health and Tropical Medicine, MPH in International Health and Development, 2006
• Tulane University School of Medicine, MD, 2012
• University of Virginia School of Medicine, Residency in Internal Medicine, 2015
• Massachusetts General Hospital, Fellowship in Infectious Disease, 2017
• Massachusetts General Hospital, Fellowship in Medical Microbiology, 2018

Dr. Coffey's research centers on antimicrobial stewardship, diagnostic stewardship, and prevention of healthcare-associated infections, with specialized focus on Clostridoides difficile infection and hospital epidemiology. She served as Subject Matter Expert for the VA Incident Command during the COVID-19 pandemic, contributing critical insights on transmission dynamics and infection control.

Her publication record (2012-2021) reveals evolving expertise from diagnostic case studies to pandemic response, with recent work analyzing SARS-CoV-2 transmission in congregate settings, antibiotic use during COVID-19, and nursing home safety protocols. Key themes include optimizing diagnostic pathways, reducing unnecessary antibiotic exposure, and developing evidence-based infection prevention strategies across healthcare environments.

Scientific Awards:

No awards documented in source material.

Dr. Coffey's leadership roles include VA hospital epidemiology oversight and multi-institutional collaborative research, though student mentorship details are unreported. Her work with the SHEA Research Committee shaped national healthcare epidemiology priorities during the pandemic.

She operates within the Division of Genomic Epidemiology and Clinical Outcomes, leveraging partnerships between the University of Maryland School of Medicine and VA Maryland Healthcare System to address real-world infection control challenges through translational research.